| Filed On | Filing |
|---|---|
| 26 Oct 2026 | FORM 425 |
| 26 Oct 2026 |
8-K: Regulation FD Disclosure
Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakers |
| 21 Oct 2026 |
Form 4: Kiessling Heather, Chief Financial Officer
Sold 21,830 shares ($47.8K) |
| 16 Oct 2026 |
Form 4: Ainscow Robert, COO
Sold 22,500 shares ($47.6K) |
| 16 Oct 2026 | 144 |
| 15 Oct 2026 |
8-K: Regulation FD Disclosure
Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa |
| 14 Oct 2026 | 144 |
| 08 Oct 2026 | SCHEDULE 13D |
| 08 Oct 2026 |
Form 3: Asp Isotopes Inc., 10% owner and 1 other · ENDRA Life Sciences Inc
Holds 66,846 shares of Common Stock |
| 02 Oct 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation (“ASPI” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among ENDRA Life Sciences Inc., a Delaware corp... |
| 01 Oct 2026 |
Form 4: Ryan Robert John Andrew, Director
Bought 15,000 shares ($40.2K) |
| 30 Sep 2026 |
Form 4: Ryan Robert John Andrew, Director
Bought 8,000 shares ($21.6K) |
| 25 Sep 2026 | 144 |
| 10 Sep 2026 |
Form 4: Ainscow Robert, COO
Sold 8,438 shares ($36.2K) |
| 09 Sep 2026 | 425 |
| 09 Sep 2026 | FORM 425 |
| 08 Sep 2026 |
8-K: Regulation FD Disclosure
DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts i... |
| 04 Sep 2026 |
Form 4: Ainscow Donald George, EVP, Gen Counsel, Secretary
Sold 23,678 shares ($92.1K) |
| 04 Sep 2026 |
Form 4: Ainscow Robert, COO
Sold 25,000 shares ($97.6K) |
| 04 Sep 2026 |
Form 4: Mann Paul Elliot, Director
Sold 83,758 shares ($327K) · Sold 83,758 shares ($328K) · Sold 83,759 shares ($343K) |
Loading...